AAAAAA
Results:
1-13
|
Results: 13
Authors:
DAVIS TH
RIGAS JR
MAURER LH
PIPAS JM
OBROCEA M
TRETTER CP
SMITH EL
MEYER L
HAMMOND S
Citation: Th. Davis et al., PHASE-I TRIAL OF DOCETAXEL AND SHORT INFUSION GEMCITABINE GIVEN EVERY2 WEEKS FOR ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 642-642
Authors:
OBROCEA M
DAVIS TH
LEWIS LD
MAURER LH
PIPAS JM
SMITH EL
MEYER LP
HAMMOND S
RIGAS JR
Citation: M. Obrocea et al., PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF DOCETAXEL AND GEMCITABINE IN PATIENTS WITH ADVANCED SOLID TUMORS - A NOVEL 2 WEEK SCHEDULE, Annals of oncology, 9, 1998, pp. 363-363
Authors:
AHLES TA
SILBERFARB PM
HERNDON J
MAURER LH
KORNBLITH AB
AISNER J
PERRY MC
EATON WL
ZACHARSKI LL
GREEN MR
HOLLAND JC
Citation: Ta. Ahles et al., PSYCHOLOGIC AND NEUROPSYCHOLOGIC FUNCTIONING OF PATIENTS WITH LIMITEDSMALL-CELL LUNG-CANCER TREATED WITH CHEMOTHERAPY AND RADIATION-THERAPY WITH OR WITHOUT WARFARIN - A STUDY BY THE CANCER AND LEUKEMIA GROUP-B, Journal of clinical oncology, 16(5), 1998, pp. 1954-1960
Authors:
MAURER LH
HERNDON JE
HOLLIS DR
AISNER J
CAREY RW
SKARIN AT
PERRY MC
EATON WL
ZACHARSKI LL
HAMMOND S
GREEN MR
Citation: Lh. Maurer et al., RANDOMIZED TRIAL OF CHEMOTHERAPY AND RADIATION-THERAPY WITH OR WITHOUT WARFARIN FOR LIMITED-STAGE SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 15(11), 1997, pp. 3378-3387
Authors:
LUIKART SD
HERNDON JE
HOLLIS DR
MACDONALD M
MAURER LH
CRAWFORD J
CLAMON GH
WRIGHT J
PERRY MC
OZER H
GREEN MR
Citation: Sd. Luikart et al., PHASE-I TRIAL OF ETOPOSIDE, CARBOPLATIN, AND GM-CSF IN EXTENSIVE SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY (CALGB-8832), American journal of clinical oncology, 20(1), 1997, pp. 24-30
Authors:
LEWIS LD
MAURER LH
RIGAS JR
BEAULIEU B
NIERENBERG DW
Citation: Ld. Lewis et al., PRELIMINARY DATA ON THE EFFECT OF SCHEDULING ON THE PHARMACOKINETICS OF PACLITAXEL (TAX) COMBINED WITH IFOSFAMIDE (IFX), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 32-32
Authors:
NUGENT WC
EDNEY MT
HAMMERNESS PG
DAIN BJ
MAURER LH
RIGAS JR
Citation: Wc. Nugent et al., NONSMALL CELL LUNG-CANCER AT THE EXTREMES OF AGE - IMPACT ON DIAGNOSIS AND TREATMENT, The Annals of thoracic surgery, 63(1), 1997, pp. 193-197
Authors:
POPLACK SP
MAURER LH
Citation: Sp. Poplack et Lh. Maurer, REDUCTION IN SIZE OF A BREAST MASS DUE TO CONCURRENT CHEMOTHERAPY - PITFALLS IN MAMMOGRAPHIC FOLLOW-UP, American journal of roentgenology, 167(2), 1996, pp. 392-393
Authors:
MITCHELL EP
PERRY MC
LUIKART SD
CIRRINCIONE CT
VANECHO DA
HERNDON JE
MAURER LH
CLAMON G
GREEN MR
Citation: Ep. Mitchell et al., A PHASE I II TRIAL OF ETOPOSIDE AND CISPLATIN IN EXTENSIVE SMALL-CELLLUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY/, Lung cancer, 15(2), 1996, pp. 215-223
Authors:
CONZEN SD
KAUFMAN PA
ARVIZU C
LEMARBRE P
MAURER LH
MOTT LA
MILLS LE
Citation: Sd. Conzen et al., PHASE-II TRIAL OF TAMOXIFEN, ETOPOSIDE, MITOXANTRONE, AND CISPLATIN IN PATIENTS WITH METASTATIC BREAST-CARCINOMA, Cancer, 78(9), 1996, pp. 1906-1911
Authors:
LATTANZI SC
TOSTESON T
CHERTOFF J
MAURER LH
ODONNELL J
LEMARBRE PJ
MOTT L
DELPRETE SA
FORCIER RJ
ERNSTOFF MS
Citation: Sc. Lattanzi et al., DACARBAZINE, CISPLATIN AND CARMUSTINE, WITH OR WITHOUT TAMOXIFEN, FORMETASTATIC MELANOMA - 5-YEAR FOLLOW-UP, Melanoma research, 5(5), 1995, pp. 365-369
Authors:
MEEHAN KR
ZACHARSKI LR
MAURER LH
HOWELL AL
MEMOLI VA
ROUSSEAU SM
HUNT JA
HENKIN J
Citation: Kr. Meehan et al., STUDIES OF POSSIBLE MECHANISMS FOR THE EFFECT OF UROKINASE THERAPY INSMALL-CELL CARCINOMA OF THE LUNG, Blood coagulation & fibrinolysis, 6(2), 1995, pp. 105-112
Authors:
XUE FY
YU H
MAURER LH
MEMOLI VA
NUTILEMCMENEMY N
SCHUSTER MK
BOWDEN DW
MAO JI
NOLL WW
Citation: Fy. Xue et al., GERMLINE RET MUTATIONS IN MEN 2A AND FMTC AND THEIR DETECTION BY SIMPLE DNA DIAGNOSTIC-TESTS, Human molecular genetics, 3(4), 1994, pp. 635-638
Risultati:
1-13
|